Core Scientific (CORZR) Invested Capital (2020 - 2026)

Core Scientific's Invested Capital history runs 7 years deep, the most recent figure standing at -$220.7 million for Q1 2026.

• In Q1 2026, Invested Capital rose 28.27% year-over-year to -$220.7 million; the TTM figure through Mar 2026 stood at -$220.7 million (up 28.27% YoY), while the FY2025 annual figure was -$962.7 million, down 2.27% from the prior year.
• Invested Capital came in at -$220.7 million for Q1 2026 at Core Scientific, up from -$962.7 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $1.2 billion in Q1 2022 to a low of -$1.3 billion in Q3 2025.
• A 5-year average of -$445.5 million and a median of -$397.5 million in 2023 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital soared 912.69% in 2022 and plunged 348.5% in 2023, its largest moves.
• Core Scientific's Invested Capital stood at -$409.3 million in 2022, then plunged by 32.27% to -$541.4 million in 2023, then slumped by 73.87% to -$941.4 million in 2024, then dropped by 2.27% to -$962.7 million in 2025, then jumped by 77.08% to -$220.7 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered -$220.7 million, -$962.7 million, and -$1.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison